Viscofan, S.A.

BME:VIS Rapport sur les actions

Capitalisation boursière : €2.8b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Viscofan Bilan de santé

Santé financière contrôle des critères 5/6

Viscofan possède un total de capitaux propres de €916.8M et une dette totale de €267.4M, ce qui porte son ratio d'endettement à 29.2%. Son actif total et son passif total sont €1.4B et de €509.7M. L'EBIT de Viscofan est €185.9M ce qui fait que son ratio de couverture des intérêts 27. Elle dispose de liquidités et de placements à court terme de €52.2M.

Informations clés

29.2%

Ratio d'endettement

€267.38m

Dette

Ratio de couverture des intérêts27x
Argent liquide€52.18m
Fonds propres€916.78m
Total du passif€509.65m
Total des actifs€1.43b

Mises à jour récentes de la santé financière

Recent updates

Here's Why We Think Viscofan (BME:VIS) Might Deserve Your Attention Today

Aug 17
Here's Why We Think Viscofan (BME:VIS) Might Deserve Your Attention Today

Viscofan, S.A. (BME:VIS) Interim Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Aug 02
Viscofan, S.A. (BME:VIS) Interim Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Viscofan (BME:VIS) Shareholders Will Want The ROCE Trajectory To Continue

Jun 26
Viscofan (BME:VIS) Shareholders Will Want The ROCE Trajectory To Continue

Viscofan, S.A. (BME:VIS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Apr 20
Viscofan, S.A. (BME:VIS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Why We Think Viscofan, S.A.'s (BME:VIS) CEO Compensation Is Not Excessive At All

Apr 11
Why We Think Viscofan, S.A.'s (BME:VIS) CEO Compensation Is Not Excessive At All

Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 38% Undervaluation?

Apr 04
Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 38% Undervaluation?

Some Shareholders Feeling Restless Over Viscofan, S.A.'s (BME:VIS) P/E Ratio

Mar 18
Some Shareholders Feeling Restless Over Viscofan, S.A.'s (BME:VIS) P/E Ratio

Slowing Rates Of Return At Viscofan (BME:VIS) Leave Little Room For Excitement

Jan 17
Slowing Rates Of Return At Viscofan (BME:VIS) Leave Little Room For Excitement

Is Viscofan (BME:VIS) Using Too Much Debt?

Dec 21
Is Viscofan (BME:VIS) Using Too Much Debt?

Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 37% Undervaluation?

Nov 15
Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 37% Undervaluation?

Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Sep 20
Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Returns On Capital At Viscofan (BME:VIS) Have Stalled

Aug 29
Returns On Capital At Viscofan (BME:VIS) Have Stalled

Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 32% Undervaluation?

Aug 11
Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 32% Undervaluation?

Here's Why Viscofan (BME:VIS) Can Manage Its Debt Responsibly

May 25
Here's Why Viscofan (BME:VIS) Can Manage Its Debt Responsibly

Viscofan's (BME:VIS) Dividend Will Be Increased To €0.4374

May 04
Viscofan's (BME:VIS) Dividend Will Be Increased To €0.4374

Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching

Apr 24
Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching

The Returns At Viscofan (BME:VIS) Aren't Growing

Mar 02
The Returns At Viscofan (BME:VIS) Aren't Growing

Estimating The Intrinsic Value Of Viscofan, S.A. (BME:VIS)

Feb 16
Estimating The Intrinsic Value Of Viscofan, S.A. (BME:VIS)

Is Viscofan (BME:VIS) Using Too Much Debt?

Jan 07
Is Viscofan (BME:VIS) Using Too Much Debt?

Returns On Capital At Viscofan (BME:VIS) Have Stalled

Nov 29
Returns On Capital At Viscofan (BME:VIS) Have Stalled

Viscofan, S.A.'s (BME:VIS) Intrinsic Value Is Potentially 77% Above Its Share Price

Nov 11
Viscofan, S.A.'s (BME:VIS) Intrinsic Value Is Potentially 77% Above Its Share Price

Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Sep 01
Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Viscofan (BME:VIS) Has Some Way To Go To Become A Multi-Bagger

Aug 03
Viscofan (BME:VIS) Has Some Way To Go To Become A Multi-Bagger

Viscofan's (BME:VIS) Returns Have Hit A Wall

May 03
Viscofan's (BME:VIS) Returns Have Hit A Wall

Does Viscofan (BME:VIS) Have A Healthy Balance Sheet?

Mar 25
Does Viscofan (BME:VIS) Have A Healthy Balance Sheet?

Is Viscofan, S.A. (BME:VIS) Trading At A 38% Discount?

Mar 06
Is Viscofan, S.A. (BME:VIS) Trading At A 38% Discount?

Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching

Jan 15
Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching

Returns At Viscofan (BME:VIS) Appear To Be Weighed Down

Dec 29
Returns At Viscofan (BME:VIS) Appear To Be Weighed Down

Viscofan (BME:VIS) Has A Rock Solid Balance Sheet

Nov 24
Viscofan (BME:VIS) Has A Rock Solid Balance Sheet

Is Viscofan, S.A. (BME:VIS) Trading At A 24% Discount?

Oct 10
Is Viscofan, S.A. (BME:VIS) Trading At A 24% Discount?

With EPS Growth And More, Viscofan (BME:VIS) Is Interesting

Sep 23
With EPS Growth And More, Viscofan (BME:VIS) Is Interesting

Returns On Capital At Viscofan (BME:VIS) Have Stalled

Aug 19
Returns On Capital At Viscofan (BME:VIS) Have Stalled

Viscofan (BME:VIS) Has A Rock Solid Balance Sheet

Aug 03
Viscofan (BME:VIS) Has A Rock Solid Balance Sheet

A Look At The Fair Value Of Viscofan, S.A. (BME:VIS)

May 17
A Look At The Fair Value Of Viscofan, S.A. (BME:VIS)

Viscofan (BME:VIS) Could Easily Take On More Debt

Apr 07
Viscofan (BME:VIS) Could Easily Take On More Debt

Should We Be Excited About The Trends Of Returns At Viscofan (BME:VIS)?

Mar 04
Should We Be Excited About The Trends Of Returns At Viscofan (BME:VIS)?

Here's What Viscofan, S.A.'s (BME:VIS) Shareholder Ownership Structure Looks Like

Feb 17
Here's What Viscofan, S.A.'s (BME:VIS) Shareholder Ownership Structure Looks Like

Viscofan, S.A.'s (BME:VIS) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

Feb 02
Viscofan, S.A.'s (BME:VIS) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

A Look At The Intrinsic Value Of Viscofan, S.A. (BME:VIS)

Jan 18
A Look At The Intrinsic Value Of Viscofan, S.A. (BME:VIS)

Why Viscofan's (BME:VIS) CEO Pay Matters

Dec 26
Why Viscofan's (BME:VIS) CEO Pay Matters

Income Investors Should Know That Viscofan, S.A. (BME:VIS) Goes Ex-Dividend Soon

Dec 13
Income Investors Should Know That Viscofan, S.A. (BME:VIS) Goes Ex-Dividend Soon

Should Viscofan, S.A. (BME:VIS) Be Part Of Your Dividend Portfolio?

Dec 04
Should Viscofan, S.A. (BME:VIS) Be Part Of Your Dividend Portfolio?

The Returns At Viscofan (BME:VIS) Provide Us With Signs Of What's To Come

Nov 19
The Returns At Viscofan (BME:VIS) Provide Us With Signs Of What's To Come

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de VIS ( €800.3M ) dépassent ses passifs à court terme ( €372.0M ).

Passif à long terme: Les actifs à court terme de VIS ( €800.3M ) dépassent ses passifs à long terme ( €137.7M ).


Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de VIS ( 23.5% ) est considéré comme satisfaisant.

Réduire la dette: Le ratio d'endettement de VIS est passé de 19.6% à 29.2% au cours des 5 dernières années.

Couverture de la dette: La dette de VIS est bien couverte par le flux de trésorerie opérationnel ( 79.6% ).

Couverture des intérêts: Les paiements d'intérêts de VIS sur sa dette sont bien couverts par l'EBIT ( 27 x couverture).


Bilan


Découvrir des entreprises saines